Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila

Study ID: NCT07111039
Start Date: 2025-12
End Date: 2026-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

Airway Pressure Release Ventilation

Conventional Mechanical Ventilation

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

Study ID: NCT06139172
Start Date: 2023-09-15
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

92

Intervention / Treatment

Functional Behavioral Training (FBT)

Positive Parenting Strategies-Treatment as Usual

Sponsor

Rush University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Study ID: NCT06934239
Start Date: 2025-10-15
End Date: 2030-03-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

400000

Intervention / Treatment

Artificial intelligence (AI) decision-support tool

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing

Study ID: NCT02282969
Start Date: 2014-07-11
End Date: 2025-08-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

620

Intervention / Treatment

Interviews

Questionnaires

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of ASP3082 in Adults With Advanced Solid Tumors

Study ID: NCT05382559
Start Date: 2022-06-08
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

651

Intervention / Treatment

ASP3082

Cetuximab

Leucovorin

Oxaplatin

Fluorouracil

Irinotecan

Nanoparticle albumin-bound-paclitaxel

Gemcitabine

Docetaxel

Pembrolizumab

Cisplatin

Carboplatin

Pemetrexed

Sponsor

Astellas Pharma Inc

Source: clinicaltrials.gov

Share:
Add to list

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Study ID: NCT03364803
Start Date: 2017-11-28
End Date: 2026-11-28
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Cushing's QoL (Quality of Life Questionnaire)

Nottingham Health Profile (NHP)

Hospital Anxiety and Depression Scale (HADS)

Perceived Stress Scale (PSS)

Barratt's Impulsivity Scale (BIS)

Beck Depression Inventory (BDI)

State-Trait Anxiety Inventory (STAI)

State Food Craving Questionnaire-State (FCQ-S)

Trait Food Craving Questionnaire-Trait (FCQ-T)

Visual Analogue Scale (VAS)

Sensitivity to Reinforcement of Addictive and other Primary Rewards (STRAP-R) food variant

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

SPEARHEAD-3 Pediatric Study

Study ID: NCT05642455
Start Date: 2023-09-01
End Date: 2038-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Afamitresgene autoleucel

Sponsor

Adaptimmune

Source: clinicaltrials.gov

Share:
Add to list

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

Study ID: NCT05864976
Start Date: 2023-12-06
End Date: 2030-01-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Support Vector Machine

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial

Study ID: NCT05333458
Start Date: 2022-08-29
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

27

Intervention / Treatment

Atezolizumab

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Echocardiography Test

Selinexor

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Advanced or Recurrent Solid Tumors Treated With SHetA2

Study ID: NCT04928508
Start Date: 2022-07-27
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase1

No. of Participants

50

Intervention / Treatment

OK-1

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list